← brief for 2026-09-03 · Slowing decline

Renoprotective Effects of AdipoRon in Preclinical Models of Renal Injury: A Systematic Review and Meta-Analysis.

Article D Peer reviewed Preclinical

Key takeaways

AdipoRon is an experimental drug that copies adiponectin, a hormone made by fat tissue. Researchers pooled the results of many laboratory studies and found it reduced signs of kidney injury by switching on two cell pathways that control energy use and inflammation. Every study in this pool was in animals or cells, not people. Nothing here shows it would help a person with kidney disease.

Who did this work

Alotaibi N · Rashikh MA · Alshahrani AM · Alsaab SM · Alotaibi G · Elbadawi NE

Source

Article · PubMed, CKD progression and prevention · 2026 Sep 1
https://pubmed.ncbi.nlm.nih.gov/42690108/